Life Scientist > Biotechnology

Potential drug target, inhibitor identified for SARS-CoV-2

16 March, 2020

Two new studies out of the US show promise for the treatment of SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19).


Sartorius BIOSTAT STR Generation 3 bioreactor with BIOBRAIN automation platform

11 March, 2020

Engineered to address the rigorous requirements and complexity of biologics manufacture, Sartorius's BIOSTAT STR Generation 3 bioreactor is a robust industrial platform consisting of hardware, software and consumables for single-use process development and commercial biomanufacturing.


FDA approves new drug for Duchenne muscular dystrophy

05 March, 2020

A clinical trial of the drug, known as VYONDYS 53 (golodirsen), established that it was well tolerated and acted to restore dystrophin protein.


Queensland and India form bioscience alliance

04 March, 2020

Life Sciences Queensland (LSQ) has formed a partnership with India's Association of Biotechnology Led Enterprises (ABLE).


DuPont DELRIN SC698 resin for medical devices

11 February, 2020

The DELRIN SC698 resin with integrated lubrication can help improve patient comfort and ease of use by ensuring smooth actuation of high-load drug delivery devices like inhalers, injectors and pumps.


New drug combination destroys deadly bacterial infection

30 January, 2020

The treatment has been found to completely kill a bacterial infection that can be deadly to patients with cystic fibrosis and other chronic lung conditions such as bronchiectasis.


Promising drug compounds target liver cancer

23 January, 2020

Singaporean scientists have discovered four potential drug compounds that target hepatocellular carcinoma (HCC), the most common type of liver cancer.


Blood pressure drug could help treat alcoholism

22 January, 2020

A drug used to treat high blood pressure may alleviate anxiety induced by long-term heavy alcohol use, and also halt the damage such drinking can cause to the brain's ability to grow new cells.


Human livers kept alive for one week outside the body

14 January, 2020

With novel perfusion technology, livers — even injured livers — can now be kept alive outside of the body for an entire week.


Anticancer candidate trialled in solid tumours

10 January, 2020

Life sciences company QBiotics has announced positive results from its first-in-human Phase I clinical trial of its anticancer pharmaceutical, tigilanol tiglate (EBC-46).


Alzheimer's drug candidates found to reverse broader ageing

17 December, 2019

The drug candidates may be useful for treating a broad array of conditions, and suggest a new pathway that links normal ageing to Alzheimer's disease.


Ovarian cancer shrinks by more than 50% in preclinical trial

16 December, 2019

The Hudson Institute of Medical Research has completed a preclinical study investigating Invion's Photosoft compound on mice with ovarian cancer — with promising results.


Medtech community shares the secrets of commercialisation

09 December, 2019

Saving and improving lives by making it easier to develop medical devices with electronics and software is the mission of the newly launched NSW Active MedTech Community.


Major Project Status granted for medical cannabis facilities

06 December, 2019

The Australian Government is looking to maximise the economic potential of the medicinal cannabis industry.


Contraceptive patch delivers hormone via microneedles

20 November, 2019

US scientists have developed a contraceptive patch with a novel effervescent backing that separates from an array of microneedles after one minute.


  • All content Copyright © 2020 Westwick-Farrow Pty Ltd